TY - GEN
T1 - A label-free, rapid multimarker protein impedance-based immunosensor
AU - Fairchild, Aaron B.
AU - McAferty, Kenyon
AU - Demirok, Ugur K.
AU - LaBelle, Jeffrey
PY - 2009
Y1 - 2009
N2 - A multiplexing, multimarker protein immunosensor based upon electrochemical impedance spectroscopy was designed, fabricated, and analyzed. The antibody based molecular recognition element sensor was demonstrated using five inflammatory cytokines and receptors (Figure 1). These pro- and anti-inflammatory markers are used in cellular signaling and could be useful in early detection of diseases including Multiple Sclerosis, cancer, or pathogenic infection. The disposable strip of five sensors was characterized over four orders of magnitude of target protein concentration. The assay takes only 90 seconds from sample introduction to impedance output in a label-free manner. The goal of this work is to develop a platform technology that can be made reproducible, scalable, and efficient for high throughput screening for proteomic markers of disease. These sensors detect the markers at the respective physiological ranges found in vivo, albeit in purified fashion. Electrochemical Impedance Spectroscopy (AC impedance) was chosen as the appropriate (label-free and rapid) approach resulting in signals that are discernible using a simple, rapid strip sensor platform that is readily scalable to accommodate future high throughput screening. This scalability could allow for the detection of 100's of proteins, or the antibody immunosignatures themselves.
AB - A multiplexing, multimarker protein immunosensor based upon electrochemical impedance spectroscopy was designed, fabricated, and analyzed. The antibody based molecular recognition element sensor was demonstrated using five inflammatory cytokines and receptors (Figure 1). These pro- and anti-inflammatory markers are used in cellular signaling and could be useful in early detection of diseases including Multiple Sclerosis, cancer, or pathogenic infection. The disposable strip of five sensors was characterized over four orders of magnitude of target protein concentration. The assay takes only 90 seconds from sample introduction to impedance output in a label-free manner. The goal of this work is to develop a platform technology that can be made reproducible, scalable, and efficient for high throughput screening for proteomic markers of disease. These sensors detect the markers at the respective physiological ranges found in vivo, albeit in purified fashion. Electrochemical Impedance Spectroscopy (AC impedance) was chosen as the appropriate (label-free and rapid) approach resulting in signals that are discernible using a simple, rapid strip sensor platform that is readily scalable to accommodate future high throughput screening. This scalability could allow for the detection of 100's of proteins, or the antibody immunosignatures themselves.
UR - http://www.scopus.com/inward/record.url?scp=67650672429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650672429&partnerID=8YFLogxK
U2 - 10.1109/ICCME.2009.4906678
DO - 10.1109/ICCME.2009.4906678
M3 - Conference contribution
AN - SCOPUS:67650672429
SN - 9781424433162
T3 - 2009 ICME International Conference on Complex Medical Engineering, CME 2009
BT - 2009 ICME International Conference on Complex Medical Engineering, CME 2009
T2 - 2009 ICME International Conference on Complex Medical Engineering, CME 2009
Y2 - 9 April 2009 through 11 April 2009
ER -